Science researchers at Duke University recently conducted a study that found that patients with a high genetic risk of asthma were 36% more likely to develop severe life-long asthma than those who are not genetically at risk. The researchers said, however, that the research is still in its early stages and not yet ready as a reliable clinical test.
Recent Posts
Tags: 2014, 2013, Duke University, North Carolina, Southern, BioResearch Product Faire Event, Durham, NC, Duke
Science researchers at the University of Georgia, the Charlie Norwood VA Medical Center in Augusta and the Georgia Regents University have discovered a direct relationship between Alzheimer’s disease symptoms and two specific antibodies. The discovery may lead to a much-anticipated diagnostic blood test for the disease. The research team published their findings in the Journal of Gerontology: Medical Sciences and found that as two specific proteins’ concentration increases, dementia also increases.
Tags: 2014, 2013, University of Georgia, Southern, Georgia, UGA, BioResearch Product Faire Event, Athens, GA
Science researchers at Harvard University have discovered a gene found in the most devastating forms of cancer that controls embryonic stem cell self-renewal. The gene, SALL4, enables stem cells to keep dividing rather than grow into mature cells. The gene is re-expressed in almost all cases of acute myeloid leukemia and between 10 to 30 percent of lung, ovarian, gastric, liver, breast and endometrial cancer. Researchers say they can make a strong case that the gene plays a part in tumor formation. The breakthrough marks the beginning of a search for a drug that can block the gene’s activity.
Tags: 2014, Harvard University, 2013, Northeast, Massachusetts, Boston, BioResearch Product Faire Event, Cambridge, MA, Harvard
Scientists at Georgetown University conducted a study published in Human Molecular Genetics that gives insight into a groundbreaking new strategy for treating neurodegenerative diseases featuring an unusual buildup of proteins, such as Alzheimer’s disease, Parkinson’s, frontotemporal dementia, amyotrophic lateral sclerosis, Huntington disease and Lew body dementia, to name a few. According to a Georgetown University news article, the researchers found that when the drug nilotinib is used to treat chronic myelogenous leukemia, it causes cancer cells to go into autophagy, a biological process that causes the death of cancerous tumor cells.
Tags: 2014, 2013, Georgetown University, Washington DC, Northeast, D.C., Geotwn, BioResearch Product Faire Event
Tags: 2014, 2013, University of North Carolina at Chapel Hill, North Carolina, University of North Carolina, Southern, BioResearch Product Faire Event, Front Line event, NC, Front Line, Chapel Hill, UNC, UNC-Chapel Hill
The University of California, Riverside was recently guaranteed $15 million a year in continuous funding for the University’s much anticipated medical school when Governor Jerry Brown signed the state’s budget on June 27th. The University of California, Riverside’s medical school will be the first new public medical school on the West Coast in almost 50 years and is expected to be a powerful economic force on the region. The school will also help address the low doctor-to-patient ratio in the region.
Tags: 2014, CA, 2013, University of California Riverside, Southwest, California, University of California, BioResearch Product Faire Event, Riverside, UC Riverside, UCR
Science researchers at Michigan State University recently published a study in Proceedings of the National Academy of Sciences that says they have discovered a second molecular door that can be used in creating mosquito repellant. Scientists long believed that there was only one molecular gateway in targeting disease-carrying mosquitoes, but this door is coming to a close. Pyrethroid insecticides have been used for years and work so well as an insecticide that the World Health Organiation uses them with the mosquito nets they distribute around the world.
Tags: Michigan State University, 2014, Midwest, 2013, Michigan, BioResearch Product Faire Event, MI, Front Line event, East Lansing, MSU
Scientists at Thomas Jefferson University have discovered a gene that has a powerful effect on the development of breast cancer tumors in mice. The gene EYA1 was proved to be overexpressed in luminal B, a genetic breast cancer subtype. The researchers also found that too much activity in EYA1 increases the presence of breast cancer stem cells that allow the body to resist cancer therapy and lead to a low survival rate.
Tags: 2014, 2013, Pennsylvania, Northeast, Thomas Jefferson University, Philadelphia, BioResearch Product Faire Event, Front Line event, PA, ThomJeff
Drexel University in Philadelphia recently created an entrepreneurship incubator that aims to fund and seed investment in companies ready to move into the market. According to MedCity News, the incubator will support medical and biotech startups along with a more diverse portfolio of startups.
Tags: 2014, 2013, Pennsylvania, Northeast, University of Pennsylvania, UPenn, Philadelphia, BioResearch Product Faire Event, PA
A new study by science researchers at Fred Hutchinson Cancer Research Center found that a number of lifestyle changes may be able to reduce the risk of or manage esophageal cancer. People who don’t smoke, keep their weight down, get regular exercise, eat a diet rich in fruits and vegetables, don’t eat four hours before they go to sleep, and avoid foods and beverages that give you heartburn (including caffeine, alcohol, chocolate, peppermint, onions, green peppers and foods that are high in fat) have a greatly reduced risk of getting esophageal cancer. Another Fred Hutchinson study found that cholesterol-reducing drugs are also associated with reduced risk.
Tags: 2014, 2013, Fred Hutchinson Cancer Research Center, Washington, Medical Research, WA, Northwest, cancer research, WA research, Washington Life Science, Cancer Treatment, BioResearch Product Faire Event, Seattle, research science information, Hutch, Cancer Center